(Q35981380)

11 August 2017

1 reference

3 April 2019

Where next with therapy in advanced neuroblastoma? (English)

1 reference

11 August 2017

1 reference

3 April 2019

Pinkerton CR

1

1 reference

PMCID

1971292

11 August 2017

language of work or name

English

0 references

publication date

1 March 1990

2 references

British Journal of Cancer

11 August 2017

3 April 2019

2 references

11 August 2017

3 April 2019

61

1 reference

11 August 2017

3

1 reference

11 August 2017

351-353

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1990.77

11 August 2017

0 references

cites work

Chemotherapy of advanced neuroblastoma: does adriamycin contribute?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971292

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971292

Neuroblastoma--an overview of laboratory studies aimed at inducing tumor regression by initiation of differentiation or administration of antitumor drugs

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971292

High dose carboplatin in the treatment of lung cancer and mesothelioma: a phase I dose escalation study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971292

High dose melphalan and non-cryopreserved autologous bone marrow treatment of malignant melanoma and neuroblastoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971292

Clinical evaluation of sequentially scheduled cisplatin and VM26 in neuroblastoma: response and toxicity.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971292

Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971292

A phase II study of high-dose cisplatin and VP-16 in neuroblastoma: a report from the Société Française d'Oncologie Pédiatrique

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971292

Screening for neuroblastoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971292

Coordinated use of sequentially escalated cyclophosphamide and cell-cycle-specific chemotherapy (N4SE protocol) for advanced neuroblastoma: experience with 100 patients.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971292

Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971292

Ifosfamide in previously untreated disseminated neuroblastoma. Results of Study 3A of the European Neuroblastoma Study Group

24 September 2018

1 reference

12 December 2020

Pentostatin (2'deoxycoformycin) for the treatment of lymphoid neoplasms

1 reference

12 December 2020

Carboplatin or cisplatin?

1 reference

12 December 2020

Single-agent ifosfamide in patients with recurrent neuroblastoma (ENSG study 2). European Neuroblastoma Study Group

1 reference

12 December 2020

Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogeneic or autologous marrow reconstitution

1 reference

12 December 2020

Treatment of advanced neuroblastoma with high-dose melphalan and autologous bone marrow transplantation

1 reference

12 December 2020

High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age

1 reference

12 December 2020

Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma

1 reference

12 December 2020

Long-term survival after advanced neuroblastoma

1 reference

12 December 2020

Magnetic resonance imaging for bone marrow metastases of neuroblastoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1990.77

1 reference

11 August 2017

1 reference

11 August 2017

1 reference

PMCID

1971292